Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Reneo Pharmaceuticals, Inc. (RPHM)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
2.6800-0.0300 (-1.11%)
At close: 03:59PM EST
Advertisement
Full screen
Loading interactive chart...
  • Simply Wall St.

    Is Reneo Pharmaceuticals (NASDAQ:RPHM) In A Good Position To Deliver On Growth Plans?

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

  • GlobeNewswire

    Reneo Pharmaceuticals Reports Third Quarter 2022 Financial Results

    IRVINE, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today reported financial results for the quarter ended September 30, 2022. “We continued to advance our REN001 development programs during the third quarter,” said Gregory J. Flesher, President and CEO of Reneo Pharmaceuticals. “As of today, we have

  • GlobeNewswire

    Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences

    IRVINE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, today announced that the company’s management team will participate at three upcoming healthcare conferences. Jefferies Global Healthcare Conference Date: November 15 – 17, 2022Location: The Waldorf Hilton, London, UK Piper Sandler Healthcare Conf

Advertisement
Advertisement